Insilico Biotechnology

Stuttgart, Germany Founded: 2001 • Age: 25 yrs Acquired By Yokogawa
In silico cell models are simulated for drug discovery.

About Insilico Biotechnology

Insilico Biotechnology is a Healthcare company based in Stuttgart (Germany) founded in 2001, and was acquired by Yokogawa in November 2021. In silico cell models are simulated for drug discovery. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its legal entity is Insilico Biotechnology AG.

Company details

Insilico Biotechnology was founded in 2001 in Stuttgart, Germany, within the insilico biotechnology sector. Software solutions such as Insilico Inspector for bioprocess diagnosis, Insilico Discovery for cellular network verification, and Insilico Cells for genome-based models are offered. Customized services in cell line engineering, process optimization, pharmaceutical testing, and de novo cellular network reconstruction are provided, including consulting on media development, clone selection, upscale strategies, and drug effect predictions.

  • Headquarters Stuttgart, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website insilico-biotechnology.com
  • Social LinkedIn X
  • Acquired by Yokogawa (Nov 2021)
  • Legal Name Insilico Biotechnology Ag
Key Metrics
  • Latest Funding Round
    $281.44K (USD), Grant

    Sep 2015

  • Investors
    Yokogawa

    & 1 more

  • Acquired by
    Yokogawa

    (Nov 2021)

Funding Insights of Insilico Biotechnology

  • Total Rounds 2
  • Last Round Grant β€” $281,440
  • First Round $342,500

    (Jul 2007)

  • Investors Count 1

All 2 funding rounds of Insilico Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2015$281,440Grant––
–
Jul 2007$342,500Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Insilico Biotechnology

Insilico Biotechnology has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Yokogawa and BMBF.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Education and research policies are overseen by the ministry.
1955bmbf.deBerlin, Germany
Cloud-based industrial automation and process control solutions are offered.
1915yokogawa.comTokyo, Japan
Premium access

Investor details for Insilico Biotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Insilico Biotechnology

8 people are tracked at Insilico Biotechnology (3 in leadership, 5 in team).

NameRoleGroup
Yasuhito Murato
Managing Director OperationsLeadership
Brett Lepore
PresidentLeadership
Jakob Kirch
Head of Modeling and SimulationLeadership
Atul Mahadev Vhanmarathi
Data ScientistTeam
Lukas Nortmann
Wissenschaftlicher ProgrammiererTeam
Amin Mirzaei, PhD
Senior Data ScientistTeam
Joachim Bucher
Senior Data ScientistTeam
Maike Naber
Senior Software Entwickler:inTeam
Premium access

Complete people profiles for Insilico Biotechnology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Insilico Biotechnology

4 dated milestones of Insilico Biotechnology across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Insilico Biotechnology is founded.
  2. Funding First funding round of $342K.
  3. Funding Latest funding round, Grant, of $281K.
  4. Exit Acquired by Yokogawa.

Web traffic of Insilico Biotechnology

The website of Insilico Biotechnology (insilico-biotechnology.com) receives about 2K visits a month.

  • Monthly visits
    2K

    ▼ 1.6% vs previous month

Similar websites

Websites whose visitors overlap most with Insilico Biotechnology. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bluetractorsoftware.co.uk
100%
View details
softzymics.com
softzymics.com
100%
–
ludesi.com
100%
View details
broad.mit.edu
broad.mit.edu
100%
–
phenosystems.com
100%
680.7K#13,325,283View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Insilico Biotechnology

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Insilico Biotechnology

Premium access

Complete news archive for Insilico Biotechnology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Insilico Biotechnology

Insilico Biotechnology was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Insilico Biotechnology is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.

Insilico Biotechnology was founded in 2001 in Stuttgart, Germany, within the insilico biotechnology sector. Software solutions such as Insilico Inspector for bioprocess diagnosis, Insilico Discovery for cellular network verification, and Insilico Cells for genome-based models are offered. Customized services in cell line engineering, process optimization, pharmaceutical testing, and de novo cellular network reconstruction are provided, including consulting on media development, clone selection, upscale strategies, and drug effect predictions.

Insilico Biotechnology has 2 investors. Key investors include Yokogawa, and BMBF.

Insilico Biotechnology operates through Insilico Biotechnology Ag.

Yes. Insilico Biotechnology was acquired by Yokogawa in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available